Court Rules for NaPro In Patent Dispute over Cancer Drug

Law360, New York (October 8, 2003, 12:00 AM EDT) -- The Federal District Court in the Western District of Pennsylvania ruled in favor of NaPro BioTherapeutics in its patent infringement suit against generic rival Mylan Laboratories, according to a statement issued by NaPro.

The Court found that inventors listed on the NaPro patents were the first to discover the compositions and methods claimed in the patents for the cancer drug paclitaxel. Paclitaxel is the generic name for the cancer drug Taxol, originally made by Bristol-Myers Squibb.

A trial on the remaining issues in the case is...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.